Katia Vitale

Dr. Katia Vitale


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in International Journal of Biometeorology
Verified
Journal Article
Open access
PDF file
MFMario Fontana
Mario Fontana
Matteo VitaliMatteo Vitali
Matteo Vitali
JPJole Del Prete
Jole Del Prete
SBSalvatore Borzì
Salvatore Borzì
APAngela Pozzoli
Angela Pozzoli
Carmela ProtanoCarmela Protano
Carmela Protano
Respiratory diseases are extremely common conditions worldwide with a high social and economic impact. The aim of this systematic review was to summarize the scientific evidence on the efficacy of thermal inhalation treatments to manage the signs and symptoms of all type of upper and lower respiratory diseases. The review was conducted according to the PRISMA recommendations. The protocol was registered in the PROSPERO platform (ID: CRD42024510869). The bibliographic search was performed using PubMed, Scopus and Web of Science databases without time limits up to January 2nd 2025. All experimental and semi-experimental studies conducted on humans, published in Italian and English, aimed to evaluate the effects of thermal inhalation treatments in the treatment of respiratory diseases were considered eligible. The quality of the studies was assessed using the CLEAR NPT scale. Overall, 27 studies were included, related to chronic and chronic-recurrent upper and lower respiratory tract diseases. The results agree on beneficial effects of thermal waters use, with an improvement in the sensation of nasal obstruction, rhinorrhea, muco-ciliary transport time and lung function parameters. The therapeutic effects determined by thermal inhalation treatments is attributed to the composition and biochemical activity of the different waters, which lead, among other effects, to a regularization of the activity of the immune system. The results, although agreeing and encouraging, cannot be definitive due to the limitations of the studies included, especially their low quality and heterogeneity. Therefore, further clinical studies should be conducted using more appropriate methodologies, study designs and statistical analysis techniques.

7 November 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Federica ValerianiFederica Valeriani
Federica Valeriani
Carmela ProtanoCarmela Protano
Carmela Protano
APAngela Pozzoli
Angela Pozzoli
KVKatia Vitale
Katia Vitale
FLFabrizio Liguori
Fabrizio Liguori
Francesca GallèFrancesca Gallè
Francesca Gallè
Background. Causing approximately 8 million deaths each year, tobacco smoking represents a significant public health concern. Evidence shows that smoking significantly impairs antibody production and immune cell activity following vaccination. Objectives. This review aims to provide a comprehensive overview of the literature regarding how smoking reduces the effectiveness of active immunization by affecting vaccine-induced immune response. Methods. This study was performed according to the PRISMA guidelines, and the protocol was registered on the PROSPERO platform (ID: CRD42024582638). PubMed, Scopus and Web of Science were consulted as bibliographic and citation databases. Studies published in Italian and English and that aimed to investigate the effects of exposure to active and passive tobacco smoking on vaccine-induced immune response were included. Results. Thirty-four studies were selected. Overall, a decrease in antibody levels and avidity and in immune cell production were observed in individuals exposed to smoke. The meta-analysis showed a weighted mean difference between smokers and non-smokers equal to 0.65 (95% CI: 0.10–1.19, p = 0.02) for vaccinations against COVID-19, influenza, pneumococcus, HBV, HPV, tetanus, pertussis, polio, haemophilus influenzae type b, measles–mumps–rubella, and recurrent urinary tract infections. Conclusions. Smoking cessation campaigns should be considered in order to increase the effectiveness of vaccination programs. Furthermore, the opportunity to adopt different vaccine dosing schemes for smokers and non-smokers, especially in acute epidemics, should be considered.

3 November 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Carmela ProtanoCarmela Protano
Carmela Protano
Federica ValerianiFederica Valeriani
Federica Valeriani
KVKatia Vitale
Katia Vitale
JPJole Del Prete
Jole Del Prete
FLFabrizio Liguori
Fabrizio Liguori
Francesca GallèFrancesca Gallè
Francesca Gallè
Background: Many human activities release harmful substances, contaminating the air, water, and soil. Since exposure to environmental pollutants is currently unavoidable, it is important to verify how these compounds may influence individual immune responses to vaccines. Methods: This review was conducted in accordance with the PRISMA statement. The protocol was registered on the PROSPERO platform with the following ID: CRD42024582592. We evaluated all observational, semi-experimental, and experimental studies written in both Italian and English that reported possible effects of exposure to environmental pollutants on the production of vaccine-induced antibodies. Results: Forty-two studies were included. The effects of pollutants were examined mainly in terms of antibody production in relation to mumps, measles and rubella, diphtheria and tetanus, hepatitis A and B, Haemophilus influenzae type B, influenza, tuberculosis, pertussis, Japanese encephalitis, poliomyelitis, and COVID-19 vaccines. Perfluorinated compounds were the most studied pollutants. Conclusions: Correlations between exposure to pollutants and reductions in antibody production were found in quite all the selected studies, suggesting that pollution control policies could contribute to increase the efficacy of vaccination campaigns. However, the heterogeneity of the examined studies did not allow us to perform a meta-analysis, and the literature on each type of vaccine or pollutant is still too limited to generate robust evidence. In order to confirm the findings of the present systematic review, and in the perspective of establishing possible exposure limit values for each type of pollutant, further research in this field is required.

30 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Carmela ProtanoCarmela Protano
Carmela Protano
Federica ValerianiFederica Valeriani
Federica Valeriani
Patrizia CalellaPatrizia Calella
Patrizia Calella
GCGIUSEPPINA CAGGIANO
GIUSEPPINA CAGGIANO
Annalisa BARGELLINIAnnalisa BARGELLINI
Annalisa BARGELLINI
Francesca GallèFrancesca Gallè
Francesca Gallè
Background/Objectives: Food technology neophobia (FTN), defined as the reluctance to accept or consume foods produced with novel or emerging food technologies, represents a psychological barrier to the adoption of sustainable and innovative dietary practices. This cross-sectional study investigated the prevalence of food technology neophobia and its associated factors among Italian university students. Methods: A total of 1788 undergraduates from 13 universities completed a validated online questionnaire between February and October 2024. The instrument included the Food Technology Neophobia Scale (FTNS), environmental attitude items, and demographic and dietary questions. Results: The mean FTNS score was 51.2 ± 14.0, suggesting moderate levels of neophobia. Multivariate logistic regression identified several factors inversely associated with neophobia: male gender (OR = 0.73, p = 0.003), paternal university education (OR = 0.73, p = 0.024), studying in Northern Italy (OR = 0.64, p < 0.001), dietary supplement use (OR = 0.74, p = 0.003), and pro-environmental attitudes (OR = 0.97, p < 0.001). Conversely, being a commuter student was associated with increased neophobia (OR = 1.29, p = 0.031). Conclusions: These findings highlight the influence of socio-demographic, behavioral, and attitudinal factors on the acceptance of new food technologies. Tailored strategies are recommended to address FTN in specific subgroups, particularly among female, commuter, and Southern Italian students, to enhance receptivity to food innovation and support sustainable dietary transitions.

19 June 2026 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
AAArianna Antonucci
Arianna Antonucci
Gabriele D'AnconaGabriele D'Ancona
Gabriele D'Ancona
LGLaura Grisolia
Laura Grisolia
APAngela Pozzoli
Angela Pozzoli
KVKatia Vitale
Katia Vitale
CPCarmela Protano
Carmela Protano